Indian drugmaker Mankind Pharma Ltd on Thursday said it has signed a deal to buy Bharat Serums & Vaccines Ltd (BSV), from private equity firm Advent International for Rs 13,630 crores ($1.63 billion).
Register now to enjoy 3 free articles per month,
or log in to continue reading.
Stay informed with complimentary articles each month
Gain access to our exclusive newsletters delivered directly to your inbox
Be the first to know about all our summits!
Already a Subscriber? Log in
